AAA

Affinity Asset Advisors Portfolio holdings

AUM $1.07B
1-Year Est. Return 86.9%
This Quarter Est. Return
1 Year Est. Return
+86.9%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$676M
AUM Growth
+$37.5M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
109
New
Increased
Reduced
Closed

Top Buys

1 +$33.7M
2 +$32M
3 +$9.71M
4
LXEO icon
Lexeo Therapeutics
LXEO
+$8.48M
5
ELVN icon
Enliven Therapeutics
ELVN
+$8.02M

Top Sells

1 +$19.9M
2 +$16.8M
3 +$13.3M
4
CNTA
Centessa Pharmaceuticals
CNTA
+$8.5M
5
INZY
Inozyme Pharma
INZY
+$8.47M

Sector Composition

1 Healthcare 95.02%
2 Financials 0.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AKBA icon
26
Akebia Therapeutics
AKBA
$443M
$7.1M 0.97%
1,950,000
+450,000
INZY
27
DELISTED
Inozyme Pharma
INZY
$7M 0.96%
1,749,359
-2,118,351
AUTL
28
Autolus Therapeutics
AUTL
$365M
$6.94M 0.95%
3,045,000
ORKA
29
Oruka Therapeutics
ORKA
$1.31B
$6.76M 0.92%
603,479
+58,117
BBIO icon
30
BridgeBio Pharma
BBIO
$12.8B
$6.48M 0.88%
150,000
-150,000
VRDN icon
31
Viridian Therapeutics
VRDN
$2.74B
$5.45M 0.74%
390,000
AXSM icon
32
Axsome Therapeutics
AXSM
$7.04B
$5.22M 0.71%
50,000
-50,000
ERAS icon
33
Erasca
ERAS
$732M
$5.19M 0.71%
4,085,787
+744,268
NAMS icon
34
NewAmsterdam Pharma
NAMS
$4.35B
$4.98M 0.68%
275,000
-50,000
CBIO
35
Crescent Biopharma
CBIO
$219M
$4.52M 0.62%
+280,031
ROIV icon
36
Roivant Sciences
ROIV
$14.1B
$4.51M 0.62%
400,000
+250,000
CRNX icon
37
Crinetics Pharmaceuticals
CRNX
$4.05B
$4.38M 0.6%
152,252
PCVX icon
38
Vaxcyte
PCVX
$6.37B
$4.06M 0.56%
125,000
+100,000
PCSC
39
Perceptive Capital Solutions
PCSC
$3.71M 0.51%
350,000
MRUS icon
40
Merus
MRUS
$7.28B
$3.68M 0.5%
70,000
-251,962
CATX icon
41
Perspective Therapeutics
CATX
$155M
$3.61M 0.49%
1,050,000
-1,174,196
AVTX icon
42
Avalo Therapeutics
AVTX
$274M
$3.03M 0.41%
607,872
-49,282
OACCU
43
Oaktree Acquisition Corp III Life Sciences Unit
OACCU
$2.65M 0.36%
250,000
JAZZ icon
44
Jazz Pharmaceuticals
JAZZ
$8.57B
$2.65M 0.36%
+25,000
MNPR icon
45
Monopar Therapeutics
MNPR
$521M
$2.42M 0.33%
67,500
+5,500
RAPP
46
Rapport Therapeutics
RAPP
$1.16B
$2.27M 0.31%
+199,643
GERN icon
47
Geron
GERN
$715M
$2.12M 0.29%
1,500,000
THRD
48
DELISTED
Third Harmonic Bio
THRD
$2.01M 0.27%
370,000
CGEM icon
49
Cullinan Oncology
CGEM
$505M
$1.99M 0.27%
263,817
NAMSW icon
50
NewAmsterdam Pharma Warrant
NAMSW
$1.96M 0.27%
245,000
+3,043